Evidence map›Paper›PMID 40150613›Full record

ArticleChildren (Basel, Switzerland)2025

Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated.

Delma J Nieves, M Tuan Tran, Jasjit Singh, Negar Ashouri, Tricia Morphew, Jennifer G Lusk, Felice C Adler-Shohet, Rachel Marano, Stephanie Osborne, Jennifer Strickland and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Children (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Remdesivir in COVID-19: A Focus on Pediatric Cardiac Patients.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Review
  3. Remdesivir in COVID-19: pros and cons.Frontiers in pharmacology · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Delma J NievesDivision of Infectious Diseases, Department of Pediatrics, CHOC Children's Hospital, University of California, Orange, CA 92868, USA.ORCID 0000-0002-6481-7111
M Tuan TranDivision of Infectious Diseases, Department of Pharmacy, CHOC Children's Hospital, Orange, CA 92868, USA.ORCID 0000-0002-9593-4847
Jasjit SinghDivision of Infectious Diseases, Department of Pediatrics, CHOC Children's Hospital, University of California, Orange, CA 92868, USA.
Negar AshouriDivision of Infectious Diseases, Department of Pediatrics, CHOC Children's Hospital, University of California, Orange, CA 92868, USA.
Tricia MorphewCHOC Research Institute, Orange, CA 92868, USA.
Jennifer G LuskDivision of Hospitalist Medicine, Department of Pediatrics, CHOC Children's Hospital, University of California, Orange, CA 92868, USA.
Felice C Adler-ShohetHarbor-UCLA Medical Center, Torrance, CA 90509, USA.
Rachel MaranoRady Children's Hospital, University of California, San Diego, CA 92123, USA.ORCID 0000-0002-5924-3790
Stephanie OsborneCHOC Research Institute, Orange, CA 92868, USA.
Jennifer StricklandDivision of Infectious Diseases, CHOC Children's Hospital, Orange, CA 92868, USA.
Antonio C ArrietaDivision of Infectious Diseases, Department of Pediatrics, CHOC Children's Hospital, University of California, Orange, CA 92868, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antiviralpediatric COVID-19RemdesivirSARS-CoV-2

Identifiers

PMID40150613
PMCPMC11941674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.